Search Results for: WSE

Braster: is the company in danger of bankruptcy?
|

Braster: is the company in danger of bankruptcy?

Braster drew up a restructuring plan on 19 October 2020. The application was submitted to the court together with the proposals for the arrangement of debts to creditors. The adopted measures are to protect the company from bankruptcy, informs money.pl. Innovative Braster device with great vision Initially, the company developed the Braster system for self-control…

Former CEO of AstraZeneca on the Board of Genomtec
|

Former CEO of AstraZeneca on the Board of Genomtec

Jarek Oleszczuk was appointed to the board of the Polish start-up Genomtec. As Chief Business Officer (CBO) he will be responsible for further development and implementation of the business strategy. Will Oleszczuk’s experience gained in managing large pharmaceutical corporations help Genomtec to grow faster? AstraZeneca, AbbVie, Abbott, Novartis… Jarek Oleszczuk has many years of experience…

MedApp: Krzysztof Medrala new president
|

MedApp: Krzysztof Medrala new president

The telemedicine company MedApp appointed a new president – Krzysztof Medrala. The main goals that he faces will be to accelerate the commercialisation of CarnaLife products and support the company’s entry into the main market of the WSE. Krzysztof Medrala has extensive managerial experience. In his career he has held, among others, the positions of…

Selvita: New company and new supervisory board
| |

Selvita: New company and new supervisory board

The last few days have brought a lot of changes in the biotechnological company Selvita. The company’s shareholders agreed to split the company and appoint four new members of the supervisory board of Ryvu Therapeutics. Selvita also announced the launch of phase I clinical trials of its acute myeloid leukemia drug (SEL120). Selvita separates Ryvu…

PBKM will go public in Frankfurt?
|

PBKM will go public in Frankfurt?

Polski Bank Komórek Macierzystych (PBKM), a steam cell bank, is planning further acquisitions and is looking for a source of financing for them. One of the most probable options is to go public on the Frankfurt Stock Exchange. PBKM: A good time for acquisitions Despite the failure of the Cryo-Save acquisition negotiations (as we informed…

Tuberculosis vaccine returns to production line
| |

Tuberculosis vaccine returns to production line

At the turn of 2018 and 2019 Biomed-Lublin had problems with the quality of the Onko BCG 100 medicinal product and the BCG 10 tuberculosis vaccine. In 2019, none of the tested series was defective. Newborns will get a tuberculosis vaccine The tuberculosis vaccine is an obligatory vaccination of newborns before discharge from the neonatal…

Big plans for Invention Med
|

Big plans for Invention Med

Invention Med, a Polish technology company specializing in virtual and augmented reality solutions, has ambitious development plans for the coming years. The company plans to build, among others, the Centre for Innovative Medical Simulations in Bydgoszcz. It also wants to develop a virtual syringe. Additionally, Invention Med hopes to be switched to the Warsaw Stock…

PBKM seeks targets for further acquisitions
|

PBKM seeks targets for further acquisitions

The Polish bank (PBKM) is currently analysing acquisition options and joint ventures, both in and outside Europe. The Company has defined a list of possible transaction objectives to be considered first. They concern both companies operating in the countries where PBKM is present and companies from new markets. Priority transactions may be executed in the…

Mandatory vaccinations also for adults?
| | |

Mandatory vaccinations also for adults?

The Ministry of Health is planning to amend the vaccination calendar.  “We want to change the current vaccination rhythm with the vaccination calendar from birth, 24 hours after birth to infancy. – Zbigniew Król, Undersecretary of State at the Ministry of Foreign Affairs, announced in an interview with the newseria.pl portal. A novelty is that…